Emerging data suggest Retatrutide , a dual stimulator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , could offer a significant step forward for obesity management . https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide